Surviving intensive care: A systematic review of healthcare resource use after hospital discharge

Critical Care Medicine

Volumn 41, Issue 8, 2013, Pages 1832-1843

  Lone, Nazir I ^a,b   Seretny, Marta ^b   Wild, Sarah H ^a   Rowan, Kathryn M ^c   Murray, Gordon D ^a   Walsh, Timothy S ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c and London School of Hygiene Tropical Medicine   (United Kingdom)

Author keywords

Cost of illness; Critical illness; Healthcare costs; Intensive care; Survivors

Indexed keywords

ARTICLE; DATA BASE; ELECTRONIC MEDICAL RECORD; FOLLOW UP; HEALTH CARE COST; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

AGE FACTORS; COMORBIDITY; HEALTH SERVICES; HUMANS; INTENSIVE CARE UNITS; ORGAN DYSFUNCTION SCORES; PATIENT DISCHARGE; RESPIRATION, ARTIFICIAL; SURVIVORS;

EID: 84880960565     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31828a409c     Document Type: Article

References (56)

1. Amaral AC, Rubenfeld GD: The future of critical care. Curr Opin Crit Care 2009; 15:308-313
2. Seferian EG, Afessa B: Demographic and clinical variation of adult intensive care unit utilization from a geographically defined population. Crit Care Med 2006; 34:2113-2119
3. Cuthbertson BH, Roughton S, Jenkinson D, et al: Quality of life in the five years after intensive care: A cohort study. Crit Care 2010; 14:R6
4. Angus DC, Carlet J; 2002 Brussels Roundtable Participants: Surviving intensive care: A report from the 2002 Brussels Roundtable. Intensive Care Med 2003; 29:368-377
5. Gyldmark M: A review of cost studies of intensive care units: Problems with the cost concept. Crit Care Med 1995; 23:964-972
6. Negrini D, Sheppard L, Mills GH, et al: International Programme for Resource Use in Critical Care (IPOC)-A methodology and initial results of cost and provision in four European countries. Acta Anaesthesiol Scand 2006; 50:72-79
7. Edbrooke DL, Stevens VG, Hibbert CL, et al: A new method of accurately identifying costs of individual patients in intensive care: The initial results. Intensive Care Med 1997; 23:645-650
8. Cuthbertson BH, Rattray J, Campbell MK, et al; PRaCTICaL study group: The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: A pragmatic randomised controlled trial. BMJ 2009; 339:b3723
9. NICE: Guide to the methods of technology appraisal. London, National Institute of Health and Clinical Excellence, 2008. Available at: http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf. Accessed August 10, 2011
10. Peek GJ, Mugford M, Tiruvoipati R, et al; CESAR trial collaboration: Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial. Lancet 2009; 374:1351-1363
11. Coughlin MT, Angus DC: Economic evaluation of new therapies in critical illness. Crit Care Med 2003; 31(1 Suppl):S7-16
12. OECD: Organisation for economic cooperation and development. Price indices (main economic indicators).2011. Available at: http://stats.oecd.org/ Index.aspx?querytype=view&queryname=221. Accessed August 10, 2011
13. OECD: Organisation for economic co-operation and development. Purchasing power parity statistics:4. PPPs and exchange rates. Available at: http://stats.oecd.org/Index.aspx?datasetcode=SNA-TABLE4. Accessed August 10, 2011
14. Fox-Rushby J, Cairns J. Economic Evaluation. Maidenhead, UK, Open University Press, 2005
15. Drummond MF, Jefferson TO: Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996; 313:275-283
16. von Elm E, Altman DG, Egger M, et al; STROBE Initiative: Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. BMJ 2007; 335:806-808
17. Schulz KF, Altman DG, Moher D; CONSORT Group: CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340:c332
18. Daly BJ, Douglas SL, Kelley CG, et al: Trial of a disease management program to reduce hospital readmissions of the chronically critically ill. Chest 2005; 128:507-517
19. Hamel MB, Phillips RS, Davis RB, et al: Are aggressive treatment strategies less cost-effective for older patients? The case of ventilator support and aggressive care for patients with acute respiratory failure. J Am Geriatr Soc 2001; 49:382-390
20. Douglas SL, Daly BJ, Brennan PF, et al: Hospital readmission among long-term ventilator patients. Chest 2001; 120:1278-1286
21. Cheung AM, Tansey CM, Tomlinson G, et al: Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome. Am J Respir Crit Care Med 2006; 174:538-544
22. Douglas SL, Daly BJ, Kelley CG, et al: Chronically critically ill patients: Health-related quality of life and resource use after a disease management intervention. Am J Crit Care 2007; 16:447-457
23. Douglas SL, Daly BJ, Gordon N, et al: Survival and quality of life: Short-term versus long-term ventilator patients. Crit Care Med 2002; 30:2655-2662
24. Unroe M, Kahn JM, Carson SS, et al: One-year trajectories of care and resource utilization for recipients of prolonged mechanical ventilation: A cohort study. Ann Intern Med 2010; 153:167-175
25. Jones C, Skirrow P, Griffiths RD, et al: Rehabilitation after critical illness: A randomized, controlled trial. Crit Care Med 2003; 31:2456-2461
26. Lipsett PA, Swoboda SM, Dickerson J, et al: Survival and functional outcome after prolonged intensive care unit stay. Ann Surg 2000; 231:262-268
27. Williams TA, Knuiman MW, Finn JC, et al: Effect of an episode of critical illness on subsequent hospitalisation: A linked data study. Anaesthesia 2010; 65:172-177
28. Keenan SP, Dodek P, Chan K, et al: Intensive care unit survivors have fewer hospital readmissions and readmission days than other hospitalized patients in British Columbia. Crit Care Med 2004; 32:391-398
29. Wunsch H, Guerra C, Barnato AE, et al: Three-year outcomes for Medicare beneficiaries who survive intensive care. JAMA 2010; 303:849-856
30. Clermont G, Kong L, Weissfeld LA, et al; NHLBI ARDS Clinical Trials Network: The effect of pulmonary artery catheter use on costs and long-term outcomes of acute lung injury. PLoS One 2011; 6:e22512
31. Herridge MS, Tansey CM, Matté A, et al; Canadian Critical Care Trials Group: Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011; 364:1293-1304
32. Lee H, Doig CJ, Ghali WA, et al: Detailed cost analysis of care for survivors of severe sepsis. Crit Care Med 2004; 32:981-985
33. Manns B, Doig CJ, Lee H, et al: Cost of acute renal failure requiring dialysis in the intensive care unit: Clinical and resource implications of renal recovery. Crit Care Med 2003; 31:449-455
34. Hamel MB, Phillips RS, Davis RB, et al: Outcomes and cost-effectiveness of ventilator support and aggressive care for patients with acute respiratory failure due to pneumonia or acute respiratory distress syndrome. Am J Med 2000; 109:614-620
35. Elliott D: Costing intensive care services: A review of study methods, results and limitations. Aust Crit Care 1997; 10:55-63
36. Luce JM, Rubenfeld GD: Can health care costs be reduced by limiting intensive care at the end of life? Am J Respir Crit Care Med 2002; 165:750-754
37. OECD: Organisation for economic co-operation and development. Purchasing power parities. 2011. Available at: http://www.oecd.org/document/5/0,3746,en- 2649-34347-45854149-1-1-1-1,00.html. Accessed August 10, 2011
38. Oeyen SG, Vandijck DM, Benoit DD, et al: Quality of life after intensive care: A systematic review of the literature. Crit Care Med 2010; 38:2386-2400
39. Williams TA, Dobb GJ, Finn JC, et al: Long-term survival from intensive care: A review. Intensive Care Med 2005; 31:1306-1315
40. Angus DC, Sirio CA, Clermont G, et al: International comparisons of critical care outcome and resource consumption. Crit Care Clin 1997; 13:389-407
41. Emanuel EJ, Emanuel LL: The economics of dying. The illusion of cost savings at the end of life. N Engl J Med 1994; 330:540-544
42. Taira DA, Seto TB, Siegrist R, et al: Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials. Am Heart J 2003; 145:452-458
43. Kahn JM: The evolving role of dedicated weaning facilities in critical care. Intensive Care Med 2010; 36:8-10
44. Kahn JM, Benson NM, Appleby D, et al: Long-term acute care hospital utilization after critical illness. JAMA 2010; 303:2253-2259
45. Drummond M, Barbieri M, Cook J, et al: Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. Value Health 2009; 12:409-418
46. Evers SM, Struijs JN, Ament AJ, et al: International comparison of stroke cost studies. Stroke 2004; 35:1209-1215
47. Heijink R, Noethen M, Renaud T, et al: Cost of illness: An international comparison. Australia, Canada, France, Germany and The Netherlands. Health Policy 2008; 88:49-61
48. Talmor D, Shapiro N, Greenberg D, et al: When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature. Crit Care Med 2006; 34:2738-2747
49. Graf J, Mühlhoff C, Doig GS, et al: Health care costs, long-term survival, and quality of life following intensive care unit admission after cardiac arrest. Crit Care 2008; 12:R92
50. Green C, Dinnes J, Takeda AL, et al: Evaluation of the cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom. Int J Technol Assess Health Care 2006; 22:90-100
51. Ridley S, Morris S: Cost effectiveness of adult intensive care in the UK. Anaesthesia 2007; 62:547-554
52. Angus DC, Linde-Zwirble WT, Clermont G, et al; PROWESS Investigators: Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med 2003; 31:1-11
53. Cooke CR, Kahn JM, Watkins TR, et al: Cost-effectiveness of implementing low-tidal volume ventilation in patients with acute lung injury. Chest 2009; 136:79-88
54. Huang DT, Clermont G, Dremsizov TT, et al; ProCESS Investigators: Implementation of early goal-directed therapy for severe sepsis and septic shock: A decision analysis. Crit Care Med 2007; 35:2090-2100
55. Shorr AF, Susla GM, Kollef MH: Linezolid for treatment of ventilatorassociated pneumonia: A cost-effective alternative to vancomycin. Crit Care Med 2004; 32:137-143
56. Tan T, Brett SJ, Stokes T; Guideline Development Group: Rehabilitation after critical illness: Summary of NICE guidance. BMJ 2009; 338:b822